---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-22-000003"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T18:03:09.800730+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Stryker realigns into MedSurg/Neurotechnology and Orthopaedics/Spine segments effective Dec 31, 2021

## Summary
- Segments reflect new internal structure after COO transition; Pierce leads MedSurg/Neuro, Stiles leads Ortho/Spine.
- FY 2021 recast sales: MedSurg/Neuro $8,345M, Ortho/Spine $6,006M, total $14,351M.
- Q4 2021 recast sales: MedSurg/Neuro $2,429M, Ortho/Spine $1,833M, total $4,262M.
- Exhibit 99.1 provides recast historical sales for 2019, 2020, and full-year 2021.
- Change aligns with previously announced management responsibilities transition.

## SEC filing metadata
- accession: 0000310764-22-000003
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076422000003/0000310764-22-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076422000003/syk-20220114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-22-000003
- JSON: https://secwatch.observer/filing/0000310764-22-000003.json
- Plain text: https://secwatch.observer/filing/0000310764-22-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.